Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

BRADLEY MURRAY D JR — ADMIRALTY HOLDING CO insider: 2 transactions · InsiderLens

Home / Insiders / BRADLEY MURRAY D JR

BRADLEY MURRAY D JR

Director at Rubius Therapeutics, Inc. · on record since Jun 14, 2004
CHIEF FINANCIAL OFFICER at Rubius Therapeutics, Inc. · on record since Jun 14, 2004
Director at ADMIRALTY HOLDING CO · on record since May 5, 2005
Chief Financial Officer at ADMIRALTY HOLDING CO · on record since May 5, 2005

Insider trading activity of BRADLEY MURRAY D JR

Transactions on record: 2; since Jun 14, 2004

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing May 5, 2005

Figures computed from official regulatory filings — methodology.

Companies where BRADLEY MURRAY D JR has traded

ADMIRALTY HOLDING CO1 tx · May 5, 2005
Rubius Therapeutics, Inc.1 tx · Jun 14, 2004

Track record of BRADLEY MURRAY D JR

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of BRADLEY MURRAY D JR

Co-insiders of BRADLEY MURRAY D JR

AFEYAN NOUBARRubius Therapeutics, Inc.
Appelhans DannielleRubius Therapeutics, Inc.
BOONE WILLIAM C IIIADMIRALTY HOLDING CO
CAGNONI PABLO JRubius Therapeutics, Inc.
Carmona JoseRubius Therapeutics, Inc.
CARPENTER CHRISTOPHER L.Rubius Therapeutics, Inc.
COLLINGWOOD G HOWARDADMIRALTY HOLDING CO

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Coughlin Christina M.Rubius Therapeutics, Inc.

Cuss Francis MRubius Therapeutics, Inc.

Epstein David RRubius Therapeutics, Inc.

Flagship VentureLabs IV, LLCRubius Therapeutics, Inc.

Flagship Ventures Fund IV General Partner LLCRubius Therapeutics, Inc.

Flagship Ventures Fund IV, L.P.Rubius Therapeutics, Inc.

Flagship Ventures Fund IV-Rx, L.P.Rubius Therapeutics, Inc.

Flagship Ventures Fund V General Partner LLCRubius Therapeutics, Inc.

Flagship Ventures Fund V, L.P.Rubius Therapeutics, Inc.

Flagship Ventures Opportunities Fund I General Partner LLCRubius Therapeutics, Inc.

Flagship Ventures Opportunities Fund I, L.P.Rubius Therapeutics, Inc.

Flagship V VentureLabs Rx Fund, L.P.Rubius Therapeutics, Inc.

GERIENE MARCADMIRALTY HOLDING CO

Holles Natalie C.Rubius Therapeutics, Inc.

James JayCeeADMIRALTY HOLDING CO

KANIA EDWIN M JRRubius Therapeutics, Inc.

Keson-Brookes MaikenRubius Therapeutics, Inc.

LANGER ROBERTRubius Therapeutics, Inc.

LARSEN JAMES WADMIRALTY HOLDING CO

LEEMING HERBERT CADMIRALTY HOLDING CO

NISSEN TORBEN STRAIGHTRubius Therapeutics, Inc.

OH ANDREW M.Rubius Therapeutics, Inc.

Pomerantz RogerRubius Therapeutics, Inc.

Prener AnneRubius Therapeutics, Inc.

Rosenblatt MichaelRubius Therapeutics, Inc.

Schaffert SusanneRubius Therapeutics, Inc.

Sohn Catherine A.Rubius Therapeutics, Inc.

Symonds JonathanRubius Therapeutics, Inc.

Turka Laurence A.Rubius Therapeutics, Inc.

WALLACE MARCADMIRALTY HOLDING CO

Company	Filed	Type	Qty	Price	Value · USD	Src
ADMIRALTY HOLDING CO	May 5, 2005	BuyD	14,074	0.10 USD	—	SEC
Rubius Therapeutics, Inc.	Jun 14, 2004	AwardD	1,050,000	0.00 USD	—	SEC